Research Article
[Retracted] Screening of Prospective Plant Compounds as H1R and CL1R Inhibitors and Its Antiallergic Efficacy through Molecular Docking Approach
Table 3
ADMET properties of top 10/10 compounds against H1R and CL1R.
| ADMET properties | WS | IS %abs | | | CNSP | CYP3A4 | AMEST | ORAT | HT | SS | H1R | CL1R | H1R | CL1R | H1R | CL1R | H1R | CL1R | H1R | CL1R | H1R | CL1R | H1R | CL1R | H1R | CL1R | H1R | CL1R | H1R | CL1R |
| -4.72 | -2.89 | 79.15 | 34.34 | -2.71 | -2.73 | -1.45 | -1.98 | -3S | -3.44 | Yes | No | No | No | 1.88 | 2.48 | Yes | No | No | No | -4.99 | -2.98 | 70.51 | 48.12 | -2.72 | -2.73 | -1.42 | -1.50 | -3 | -3.00 | Yes | No | No | No | 1.98 | 2.53 | Yes | No | No | No | -2.81 | -2.86 | 2.016 | 48.05 | -2.73 | -2.73 | -2.04 | -1.51 | -5.49 | -3.00 | No | No | No | No | 2.75 | 2.54 | No | No | No | No | -5.124 | -6.04 | 77.06 | 92.96 | -2.72 | -3.00 | -1.47 | -0.06 | -3 | -1.55 | Yes | Yes | No | No | 2.08 | 3.13 | No | Yes | No | No | -2.952 | -3.29 | 79.83 | 64.46 | -2.83 | -2.73 | -1.003 | -1.42 | -3 | -3.00 | Yes | Yes | Yes | No | 1.83 | 2.69 | No | No | No | No | -2.892 | -3.60 | 65.00 | 83.36 | -2.73 | -2.73 | -1.48 | -0.81 | -3 | -2.78 | Yes | Yes | No | No | 2.52 | 2.21 | No | No | No | No | -3.716 | -4.02 | 45.62 | 76.50 | -2.73 | -2.73 | -1.807 | -1.14 | -3 | -3.00 | Yes | Yes | No | No | 3.316 | 2.24 | No | No | No | No | -3.75 | -2.94 | 48.70 | 31.05 | -2.73 | -2.73 | -2.209 | -1.72 | -3 | -3.00 | Yes | No | No | No | 3.532 | 2.77 | No | No | No | No | -3.85 | -4.80 | 53.22 | 67.47 | -2.73 | -2.72 | -1.601 | -1.57 | -3.00 | -3.00 | Yes | Yes | No | No | 1.937 | 2.06 | No | No | No | No | -4.358 | -3.54 | 61.73 | 94.24 | -2.90 | -2.74 | -1.096 | -0.31 | -3.00 | -2.26 | No | Yes | No | Yes | 2.327 | 2.11 | No | No | No | No |
|
|